Why SK Life Science Labs’ AACR 2026 data could put targeted protein degradation back in the oncology spotlight
What Doximity (NYSE: DOCS) CFO resignation means for governance, capital allocation, and investor confidence
Read More Pharma Industry News Game-changer for kidney disease: Novartis’ Fabhalta wins FDA approval in record time Novartis has reached a pivotal moment in the treatment of rare kidney diseases with the US Food and… byPallavi MadhirajuAugust 9, 2024